{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:53:13Z","timestamp":1793040793794,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2019-05610"],"award-info":[{"award-number":["RGPIN-2019-05610"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-165822"],"award-info":[{"award-number":["PJT-165822"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Psoriasis is an inflammatory skin disease that is characterized by keratinocyte hyperproliferation, abnormal epidermal differentiation and dysregulated lipid metabolism. Some lipid mediators of the <jats:italic>N<\/jats:italic>-acylethanolamines (NAEs) and monoacylglycerols (MAGs) can bind to cannabinoid (CB) receptors and are referred to as part of the endocannabinoidome. Their implication in psoriasis remains unknown. The aim of the present study was to characterize the endocannabinoid system and evaluate the effects of n-3-derived NAEs, namely <jats:italic>N<\/jats:italic>-eicosapentaenoyl-ethanolamine (EPEA), in psoriatic keratinocytes using a psoriatic skin model produced by tissue engineering, following the self-assembly method. Psoriatic skin substitutes had lower <jats:italic>FAAH2<\/jats:italic> expression and higher <jats:italic>MAGL<\/jats:italic>, <jats:italic>ABHD6<\/jats:italic> and <jats:italic>ABHD12<\/jats:italic> expression compared with healthy skin substitutes. Treatments with alpha-linolenic acid (ALA) increased the levels of EPEA and 1\/2-docosapentaenoyl-glycerol, showing that levels of n-3 polyunsaturated fatty acids modulate related NAE and MAG levels. Treatments of the psoriatic substitutes with 10\u00a0\u03bcM of EPEA for 7\u00a0days resulted in decreased epidermal thickness and number of Ki67 positive keratinocytes, both indicating decreased proliferation of psoriatic keratinocytes. EPEA effects on keratinocyte proliferation were inhibited by the CB<jats:sub>1<\/jats:sub> receptor antagonist rimonabant. Exogenous EPEA also diminished some inflammatory features of psoriasis. In summary, n-3-derived NAEs can reduce the psoriatic phenotype of a reconstructed psoriatic skin model.<\/jats:p>","DOI":"10.1038\/s41598-023-39185-4","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T13:03:10Z","timestamp":1690376590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["N-eicosapentaenoyl-ethanolamine decreases the proliferation of psoriatic keratinocytes in a reconstructed psoriatic skin model"],"prefix":"10.1038","volume":"13","author":[{"given":"M\u00e9lissa","family":"Simard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Rioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Flamand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxane","family":"Pouliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"key":"39185_CR1","doi-asserted-by":"publisher","unstructured":"Krueger, J. G. & Bowcock, A. Psoriasis pathophysiology: Current concepts of pathogenesis. Ann. Rheum. Dis. 64(Suppl 2), 30\u201336. (2005). https:\/\/doi.org\/10.1136\/ard.2004.031120.","DOI":"10.1136\/ard.2004.031120"},{"key":"39185_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou, X., Chen, Y., Cui, L., Shi, Y. & Guo, C. Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis. 13, 81. https:\/\/doi.org\/10.1038\/s41419-022-04523-3 (2022).","journal-title":"Cell Death Dis."},{"key":"39185_CR3","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/379777a0","volume":"379","author":"WH Boehncke","year":"1996","unstructured":"Boehncke, W. H., Dressel, D., Zollner, T. M. & Kaufmann, R. Pulling the trigger on psoriasis. Nature 379, 777. https:\/\/doi.org\/10.1038\/379777a0 (1996).","journal-title":"Nature"},{"key":"39185_CR4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes, M. A., Bowcock, A. M. & Krueger, J. G. Pathogenesis and therapy of psoriasis. Nature 445, 866\u2013873. https:\/\/doi.org\/10.1038\/nature05663 (2007).","journal-title":"Nature"},{"key":"39185_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.plefa.2012.03.009","volume":"88","author":"A Nicolaou","year":"2013","unstructured":"Nicolaou, A. Eicosanoids in skin inflammation. Prostaglandins Leukot. Essent. Fatty Acids 88, 131\u2013138. https:\/\/doi.org\/10.1016\/j.plefa.2012.03.009 (2013).","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"39185_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.961107","volume":"13","author":"M Simard","year":"2022","unstructured":"Simard, M., Morin, S., Ridha, Z. & Pouliot, R. Current knowledge of the implication of lipid mediators in psoriasis. Front. Immunol. 13, 961107. https:\/\/doi.org\/10.3389\/fimmu.2022.961107 (2022).","journal-title":"Front. Immunol."},{"key":"39185_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/intimm\/dxy087","volume":"31","author":"T Honda","year":"2019","unstructured":"Honda, T. & Kabashima, K. Prostanoids and leukotrienes in the pathophysiology of atopic dermatitis and psoriasis. Int. Immunol. 31, 589\u2013595. https:\/\/doi.org\/10.1093\/intimm\/dxy087 (2019).","journal-title":"Int. Immunol."},{"key":"39185_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/nu2030355","volume":"2","author":"PC Calder","year":"2010","unstructured":"Calder, P. C. Omega-3 fatty acids and inflammatory processes. Nutrients 2, 355\u2013374. https:\/\/doi.org\/10.3390\/nu2030355 (2010).","journal-title":"Nutrients"},{"key":"39185_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan, C. N. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92\u2013101. https:\/\/doi.org\/10.1038\/nature13479 (2014).","journal-title":"Nature"},{"key":"39185_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nrd2553","volume":"7","author":"V Di Marzo","year":"2008","unstructured":"Di Marzo, V. Targeting the endocannabinoid system: To enhance or reduce?. Nat. Rev. Drug Discov. 7, 438\u2013455. https:\/\/doi.org\/10.1038\/nrd2553 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"key":"39185_CR11","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1992","unstructured":"Devane, W. A. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946\u20131949. https:\/\/doi.org\/10.1126\/science.1470919 (1992).","journal-title":"Science"},{"key":"39185_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-d","volume":"50","author":"R Mechoulam","year":"1995","unstructured":"Mechoulam, R. et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83\u201390. https:\/\/doi.org\/10.1016\/0006-2952(95)00109-d (1995).","journal-title":"Biochem. Pharmacol."},{"key":"39185_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","volume":"215","author":"T Sugiura","year":"1995","unstructured":"Sugiura, T. et al. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89\u201397. https:\/\/doi.org\/10.1006\/bbrc.1995.2437 (1995).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"39185_CR14","doi-asserted-by":"publisher","unstructured":"Simard, M. et al. Biosynthesis and metabolism of endocannabinoids and their congeners from the monoacylglycerol and N-acyl-ethanolamine families. Biochem. Pharmacol. 205, 115261 (2022). https:\/\/doi.org\/10.1016\/j.bcp.2022.115261.","DOI":"10.1016\/j.bcp.2022.115261"},{"key":"39185_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrd.2018.115","volume":"17","author":"V Di Marzo","year":"2018","unstructured":"Di Marzo, V. New approaches and challenges to targeting the endocannabinoid system. Nat. Rev. Drug Discov. 17, 623\u2013639. https:\/\/doi.org\/10.1038\/nrd.2018.115 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"39185_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1006\/abbi.1999.1410","volume":"370","author":"T Bisogno","year":"1999","unstructured":"Bisogno, T., Delton-Vandenbroucke, I., Milone, A., Lagarde, M. & Di Marzo, V. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. Arch. Biochem. Biophys. 370, 300\u2013307. https:\/\/doi.org\/10.1006\/abbi.1999.1410 (1999).","journal-title":"Arch. Biochem. Biophys."},{"key":"39185_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2019.106337","volume":"143","author":"JE Watson","year":"2019","unstructured":"Watson, J. E., Kim, J. S. & Das, A. Emerging class of omega-3 fatty acid endocannabinoids & their derivatives. Prostaglandins Other Lipid Mediat. 143, 106337. https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.106337 (2019).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"39185_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher, P., Batkai, S. & Kunos, G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58, 389\u2013462. https:\/\/doi.org\/10.1124\/pr.58.3.2 (2006).","journal-title":"Pharmacol. Rev."},{"key":"39185_CR19","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1189\/jlb.3RU0115-021R","volume":"97","author":"C Turcotte","year":"2015","unstructured":"Turcotte, C., Chouinard, F., Lefebvre, J. S. & Flamand, N. Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites. J. Leukoc. Biol. 97, 1049\u20131070. https:\/\/doi.org\/10.1189\/jlb.3RU0115-021R (2015).","journal-title":"J. Leukoc. Biol."},{"key":"39185_CR20","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","volume":"73","author":"C Turcotte","year":"2016","unstructured":"Turcotte, C., Blanchet, M. R., Laviolette, M. & Flamand, N. The CB2 receptor and its role as a regulator of inflammation. Cell Mol. Life Sci. 73, 4449\u20134470. https:\/\/doi.org\/10.1007\/s00018-016-2300-4 (2016).","journal-title":"Cell Mol. Life Sci."},{"key":"39185_CR21","doi-asserted-by":"crossref","unstructured":"Roy, B. et al. In Skin Tissue Models for Regenerative Medicine 103\u2013128 (Elsevier, 2018).","DOI":"10.1016\/B978-0-12-810545-0.00005-X"},{"key":"39185_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jdermsci.2008.07.009","volume":"53","author":"J Jean","year":"2009","unstructured":"Jean, J., Lapointe, M., Soucy, J. & Pouliot, R. Development of an in vitro psoriatic skin model by tissue engineering. J. Dermatol. Sci. 53, 19\u201325. https:\/\/doi.org\/10.1016\/j.jdermsci.2008.07.009 (2009).","journal-title":"J. Dermatol. Sci."},{"key":"39185_CR23","doi-asserted-by":"publisher","unstructured":"Rioux, G. et al. The tissue-engineered human psoriatic skin substitute: A valuable in vitro model to identify genes with altered expression in lesional psoriasis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms19102923 (2018).","DOI":"10.3390\/ijms19102923"},{"key":"39185_CR24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.bbrep.2016.09.012","volume":"8","author":"A Duque-Fernandez","year":"2016","unstructured":"Duque-Fernandez, A. et al. A 3D-psoriatic skin model for dermatological testing: The impact of culture conditions. Biochem. Biophys. Rep. 8, 268\u2013276. https:\/\/doi.org\/10.1016\/j.bbrep.2016.09.012 (2016).","journal-title":"Biochem. Biophys. Rep."},{"key":"39185_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2021.159032","volume":"1866","author":"S Morin","year":"2021","unstructured":"Morin, S., Simard, M., Flamand, N. & Pouliot, R. Biological action of docosahexaenoic acid in a 3D tissue-engineered psoriatic skin model: Focus on the PPAR signaling pathway. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1866, 159032. https:\/\/doi.org\/10.1016\/j.bbalip.2021.159032 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"39185_CR26","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1089\/ten.TEA.2010.0463","volume":"17","author":"J Jean","year":"2011","unstructured":"Jean, J., Soucy, J. & Pouliot, R. Effects of retinoic acid on keratinocyte proliferation and differentiation in a psoriatic skin model. Tissue Eng. Part A 17, 1859\u20131868. https:\/\/doi.org\/10.1089\/ten.TEA.2010.0463 (2011).","journal-title":"Tissue Eng. Part A"},{"key":"39185_CR27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.actbio.2021.09.018","volume":"136","author":"G Rioux","year":"2021","unstructured":"Rioux, G. et al. Development of a 3D psoriatic skin model optimized for infiltration of IL-17A producing T cells: Focus on the crosstalk between T cells and psoriatic keratinocytes. Acta Biomater. 136, 210\u2013222. https:\/\/doi.org\/10.1016\/j.actbio.2021.09.018 (2021).","journal-title":"Acta Biomater."},{"key":"39185_CR28","doi-asserted-by":"publisher","unstructured":"Morin, A. et al. Application of an in vitro psoriatic skin model to study cutaneous metabolization of tazarotene. Processes. https:\/\/doi.org\/10.3390\/pr7120871 (2019).","DOI":"10.3390\/pr7120871"},{"key":"39185_CR29","doi-asserted-by":"publisher","unstructured":"Simard, M. et al. Investigation of omega-3 polyunsaturated fatty acid biological activity in a tissue-engineered skin model involving psoriatic cells. J. Investig. Dermatol. 141, 2391\u20132401 e2313. https:\/\/doi.org\/10.1016\/j.jid.2021.02.755 (2021).","DOI":"10.1016\/j.jid.2021.02.755"},{"key":"39185_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/FBP.0b013e3283566a8c","volume":"23","author":"PJ McLaughlin","year":"2012","unstructured":"McLaughlin, P. J. Reports of the death of CB1 antagonists have been greatly exaggerated: Recent preclinical findings predict improved safety in the treatment of obesity. Behav. Pharmacol. 23, 537\u2013550. https:\/\/doi.org\/10.1097\/FBP.0b013e3283566a8c (2012).","journal-title":"Behav. Pharmacol."},{"key":"39185_CR31","doi-asserted-by":"publisher","unstructured":"Maccarrone, M. et al. The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J. Biol. Chem. 278, 33896\u201333903. https:\/\/doi.org\/10.1074\/jbc.M303994200 (2003).","DOI":"10.1074\/jbc.M303994200"},{"key":"39185_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1172\/jci200316116","volume":"111","author":"ML Casanova","year":"2003","unstructured":"Casanova, M. L. et al. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J. Clin. Investig. 111, 43\u201350. https:\/\/doi.org\/10.1172\/jci200316116 (2003).","journal-title":"J. Clin. Investig."},{"key":"39185_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.yjmcc.2013.11.013","volume":"66","author":"FF Hoyer","year":"2014","unstructured":"Hoyer, F. F. et al. Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice. J. Mol. Cell. Cardiol. 66, 126\u2013132. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.11.013 (2014).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"39185_CR34","doi-asserted-by":"publisher","unstructured":"Alhouayek, M., Bottemanne, P., Makriyannis, A. & Muccioli, G. G. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation. Biochim. Biophys. Acta BBA Mol. Cell Biol. Lipids 1862, 474\u2013484. https:\/\/doi.org\/10.1016\/j.bbalip.2017.01.001 (2017).","DOI":"10.1016\/j.bbalip.2017.01.001"},{"key":"39185_CR35","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/oby.22245","volume":"26","author":"KJ Nahon","year":"2018","unstructured":"Nahon, K. J. et al. Gene expression of endocannabinoid system components in skeletal muscle and adipose tissue of South Asians and White Caucasians with overweight. Obesity (Silver Spring) 26, 1332\u20131337. https:\/\/doi.org\/10.1002\/oby.22245 (2018).","journal-title":"Obesity (Silver Spring)"},{"key":"39185_CR36","doi-asserted-by":"publisher","unstructured":"Ambrozewicz, E. et al. Pathophysiological alterations of redox signaling and endocannabinoid system in granulocytes and plasma of psoriatic patients. Cells. https:\/\/doi.org\/10.3390\/cells7100159 (2018).","DOI":"10.3390\/cells7100159"},{"key":"39185_CR37","doi-asserted-by":"publisher","unstructured":"Simard, M., Rakotoarivelo, V., Di Marzo, V. & Flamand, N. Expression and functions of the CB2 receptor in human leukocytes. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.826400 (2022).","DOI":"10.3389\/fphar.2022.826400"},{"key":"39185_CR38","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.bbalip.2008.01.006","volume":"1781","author":"A Artmann","year":"2008","unstructured":"Artmann, A. et al. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim. Biophys. Acta 1781, 200\u2013212. https:\/\/doi.org\/10.1016\/j.bbalip.2008.01.006 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"39185_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s0952-3278(03)00056-5","volume":"69","author":"S Watanabe","year":"2003","unstructured":"Watanabe, S., Doshi, M. & Hamazaki, T. n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins Leukot. Essent. Fatty Acids 69, 51\u201359. https:\/\/doi.org\/10.1016\/s0952-3278(03)00056-5 (2003).","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"39185_CR40","doi-asserted-by":"publisher","first-page":"E6034","DOI":"10.1073\/pnas.1610325114","volume":"114","author":"DR McDougle","year":"2017","unstructured":"McDougle, D. R. et al. Anti-inflammatory omega-3 endocannabinoid epoxides. Proc. Natl. Acad. Sci. U.S.A. 114, E6034\u2013E6043. https:\/\/doi.org\/10.1073\/pnas.1610325114 (2017).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"39185_CR41","first-page":"1172","volume":"273","author":"IB Adams","year":"1995","unstructured":"Adams, I. B. et al. Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J. Pharmacol. Exp. Ther. 273, 1172\u20131181 (1995).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"39185_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1021\/jm9505167","volume":"39","author":"BF Thomas","year":"1996","unstructured":"Thomas, B. F., Adams, I. B., Mascarella, S. W., Martin, B. R. & Razdan, R. K. Structure-activity analysis of anandamide analogs: Relationship to a cannabinoid pharmacophore. J. Med. Chem. 39, 471\u2013479. https:\/\/doi.org\/10.1021\/jm9505167 (1996).","journal-title":"J. Med. Chem."},{"key":"39185_CR43","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1021\/jm960752x","volume":"40","author":"T Sheskin","year":"1997","unstructured":"Sheskin, T., Hanus, L., Slager, J., Vogel, Z. & Mechoulam, R. Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J. Med. Chem. 40, 659\u2013667. https:\/\/doi.org\/10.1021\/jm960752x (1997).","journal-title":"J. Med. Chem."},{"key":"39185_CR44","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/carcin\/bgq151","volume":"31","author":"I Brown","year":"2010","unstructured":"Brown, I. et al. Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines. Carcinogenesis 31, 1584\u20131591. https:\/\/doi.org\/10.1093\/carcin\/bgq151 (2010).","journal-title":"Carcinogenesis"},{"key":"39185_CR45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.brainresbull.2021.02.011","volume":"170","author":"MM Ghanbari","year":"2021","unstructured":"Ghanbari, M. M., Loron, A. G. & Sayyah, M. The \u03c9-3 endocannabinoid docosahexaenoyl ethanolamide reduces seizure susceptibility in mice by activating cannabinoid type 1 receptors. Brain Res. Bull. 170, 74\u201380. https:\/\/doi.org\/10.1016\/j.brainresbull.2021.02.011 (2021).","journal-title":"Brain Res. Bull."},{"key":"39185_CR46","doi-asserted-by":"publisher","unstructured":"Balvers, M. G. J. et al. Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties. Biochim. Biophys. Acta BBA Mol. Cell Biol. Lipids. 1801, 1107\u20131114. https:\/\/doi.org\/10.1016\/j.bbalip.2010.06.006 (2010).","DOI":"10.1016\/j.bbalip.2010.06.006"},{"key":"39185_CR47","doi-asserted-by":"publisher","first-page":"7656","DOI":"10.1073\/pnas.90.16.7656","volume":"90","author":"CC Felder","year":"1993","unstructured":"Felder, C. C. et al. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. U. S. A. 90, 7656\u20137660. https:\/\/doi.org\/10.1073\/pnas.90.16.7656 (1993).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"39185_CR48","doi-asserted-by":"publisher","unstructured":"Seltzer, E. S., Watters, A. K., MacKenzie, D., Jr., Granat, L. M. & Zhang, D. Cannabidiol (CBD) as a promising anti-cancer drug. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12113203 (2020).","DOI":"10.3390\/cancers12113203"},{"key":"39185_CR49","doi-asserted-by":"publisher","unstructured":"Toth, K. F., Adam, D., Biro, T. & Olah, A. Cannabinoid signaling in the skin: Therapeutic potential of the \"C(ut)annabinoid\" system. Molecules. https:\/\/doi.org\/10.3390\/molecules24050918 (2019).","DOI":"10.3390\/molecules24050918"},{"key":"39185_CR50","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","volume":"36","author":"M Maccarrone","year":"2015","unstructured":"Maccarrone, M. et al. Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol. Sci. 36, 277\u2013296. https:\/\/doi.org\/10.1016\/j.tips.2015.02.008 (2015).","journal-title":"Trends Pharmacol. Sci."},{"key":"39185_CR51","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.4049\/jimmunol.1500546","volume":"197","author":"V Chiurchiu","year":"2016","unstructured":"Chiurchiu, V. et al. Anandamide suppresses proinflammatory T cell responses in vitro through type-1 cannabinoid receptor-mediated mTOR inhibition in human keratinocytes. J. Immunol. 197, 3545\u20133553. https:\/\/doi.org\/10.4049\/jimmunol.1500546 (2016).","journal-title":"J. Immunol."},{"key":"39185_CR52","doi-asserted-by":"publisher","unstructured":"Simard, M., Julien, P., Fradette, J. & Pouliot, R. Modulation of the lipid profile of reconstructed skin substitutes after essential fatty acid supplementation affects testosterone permeability. Cells. https:\/\/doi.org\/10.3390\/cells8101142 (2019).","DOI":"10.3390\/cells8101142"},{"key":"39185_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0305-4179(93)90028-7","volume":"19","author":"L Germain","year":"1993","unstructured":"Germain, L. et al. Improvement of human keratinocyte isolation and culture using thermolysin. Burns 19, 99\u2013104. https:\/\/doi.org\/10.1016\/0305-4179(93)90028-7 (1993).","journal-title":"Burns"},{"key":"39185_CR54","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1194\/jlr.RA119000424","volume":"61","author":"C Manca","year":"2020","unstructured":"Manca, C. et al. Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling. J. Lipid Res. 61, 70\u201385. https:\/\/doi.org\/10.1194\/jlr.RA119000424 (2020).","journal-title":"J. Lipid Res."},{"key":"39185_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051078","author":"M Simard","year":"2022","unstructured":"Simard, M. et al. Remodeling of the dermal extracellular matrix in a tissue-engineered psoriatic skin model by n-3 polyunsaturated fatty acids. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10051078 (2022).","journal-title":"Biomedicines."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39185-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39185-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39185-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T13:17:23Z","timestamp":1690377443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39185-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["39185"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-39185-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]},"assertion":[{"value":"8 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12113"}}